Evidence map›Paper›PMID 38102299›Full record

ArticleScientific reports2023

Prognostic and risk factor analysis of cancer patients after unplanned ICU admission: a real-world multicenter study.

Miao Wei, Mingguang Huang, Yan Duan, Donghao Wang, Xuezhong Xing, Rongxi Quan, Guoxing Zhang, Kaizhong Liu, Biao Zhu, Yong Ye and 25 more

Open access · goldAbstract readClinical StudyMulticenter Study
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Outcomes of Cancer Patients Requiring Non-elective Medical Admission to the Intensive Care Unit of a Tertiary Care Center in India: A 5-year Retrospective Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Chemotherapy-related cognitive impairment and kidney dysfunction.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 20 institutions in 1 country.

Miao WeiDepartment of Intensive Care Unit, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.
Mingguang HuangDepartment of Intensive Care Unit, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China. hmgsxzlyy@163.com.
Yan DuanDepartment of Intensive Care Unit, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi, China.
Donghao WangDepartment of Intensive Care Unit, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Xuezhong XingDepartment of Intensive Care Unit, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.
Rongxi QuanDepartment of Intensive Care Unit, Cancer Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang, China.
Guoxing ZhangDepartment of Intensive Care Unit, Gaoxin District of Jilin Cancer Hospital, Changchun, Jilin, China.
Kaizhong LiuDepartment of Intensive Care Unit, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.
Biao ZhuDepartment of Intensive Care Unit, Fudan University Affiliated Shanghai Cancer Hospital, Shanghai, China.
Yong YeDepartment of Intensive Care Unit, Fujian Cancer Hospital and Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China.
Dongmin ZhouDepartment of Intensive Care Unit, Henan Cancer Hospital, Zhengzhou, Henan, China.
Jianghong ZhaoDepartment of Intensive Care Unit, Hunan Cancer Hospital, Changsha, Hunan, China.
Gang MaDepartment of Intensive Care Unit, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China.
Zhengying JiangDepartment of Intensive Care Unit, Chongqing University Cancer Hospital, Chongqing, Sichuan, China.
Bing HuangDepartment of Intensive Care Unit, Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi, China.
Shanling XuDepartment of Intensive Care Unit, Sichuan Cancer Hospital and Institute, Chengdu, Sichuan, China.
Yun XiaoDepartment of Intensive Care Unit, Yunnan Cancer Hospital, Kunming, Yunnan, China.
Linlin ZhangDepartment of Intensive Care Unit, Anhui Province Cancer Hospital, Hefei, Anhui, China.
Hongzhi WangDepartment of Intensive Care Unit, Beijing Cancer Hospital, Beijing, China.
Ruiyun LinDepartment of Intensive Care Unit, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Shuliang MaDepartment of Intensive Care Unit, Jiangsu Cancer Hospital, Nanjing, Jiangsu, China.
Yu'an QiuDepartment of Intensive Care Unit, Jiangxi Provincial Tumor Hospital, Nanchang, Jiangxi, China.
Changsong WangDepartment of Intensive Care Unit, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
Zhen ZhengDepartment of Intensive Care Unit, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China.
Ni SunDepartment of Intensive Care Unit, Huguang District of Jilin Cancer Hospital, Changchun, Jilin, China.
Lewu XianDepartment of Intensive Care Unit, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
Ji LiDepartment of Intensive Care Unit, Hainan Cancer Hospital, Haikou, Hainan, China.
Ming ZhangDepartment of Intensive Care Unit, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China.
Zhijun GuoDepartment of Intensive Care Unit, Shandong First Medical University Affiliated Tumor Hospital, Jinan, Shandong, China.
Yong TaoDepartment of Intensive Care Unit, Nantong Tumor Hospital, Nantong, Jiangsu, China.
Li ZhangDepartment of Intensive Care Unit, Hubei Cancer Hospital, Wuhan, Hubei, China.
Xiangzhe ZhouDepartment of Intensive Care Unit, Gansu Provincial Cancer Hospital, Lanzhou, Gansu, China.
Wei ChenDepartment of Intensive Care Unit, Beijing Shijitan Hospital (Capital Medical University Cancer Hospital), Beijing, China.
Daoxie WangDepartment of Intensive Care Unit, Cancer Hospital of Zhengzhou, Zhengzhou, Henan, China.
Jiyan ChiDepartment of Intensive Care Unit, Tumor Hospital of Mudanjiang City, Mudanjiang, Heilongjiang, China.
Shanxi Medical University · CNHubei Cancer Hospital · CNJilin Province Tumor Hospital · CNTianjin Medical University Cancer Institute and Hospital · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChongqing University · CNFudan University Shanghai Cancer Center · CNFujian Medical University · CNGansu Provincial Hospital · CNGuangzhou Medical University · CNHainan Medical College Hospital · CNHangzhou Cancer Hospital · CNHarbin Medical University · CNHenan Cancer Hospital · CNHunan Cancer Hospital · CNJiangsu Cancer Hospital · CNJiangxi Provincial Cancer Hospital · CNLiaoning Cancer Hospital & Institute · CNMudanjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the occurrence and 90-day mortality of cancer patients following unplanned admission to the intensive care unit (ICU), as well as to develop a risk prediction model for their 90-day prognosis. We prospectively analyzed data from cancer patients who were admitted to the ICU without prior planning within the past 7 days, specifically between May 12, 2021, and July 12, 2021. The patients were grouped based on their 90-day survival status, and the aim was to identify the risk factors influencing their survival status. A total of 1488 cases were included in the study, with an average age of 63.2 ± 12.4 years. The most common reason for ICU admission was sepsis (n = 940, 63.2%). During their ICU stay, 29.7% of patients required vasoactive drug support (n = 442), 39.8% needed invasive mechanical ventilation support (n = 592), and 82 patients (5.5%) received renal replacement therapy. We conducted a multivariate COX proportional hazards model analysis, which revealed that BMI and a history of hypertension were protective factors. On the other hand, antitumor treatment within the 3 months prior to admission, transfer from the emergency department, general ward, or external hospital, high APACHE score, diagnosis of shock and respiratory failure, receiving invasive ventilation, and experiencing acute kidney injury (AKI) were identified as risk factors for poor prognosis within 90 days after ICU admission. The average length of stay in the ICU was 4 days, while the hospital stay duration was 18 days. A total of 415 patients died within 90 days after ICU admission, resulting in a mortality rate of 27.9%. We selected 8 indicators to construct the predictive model, which demonstrated good discrimination and calibration. The prognosis of cancer patients who are unplanned transferred to the ICU is generally poor. Assessing the risk factors and developing a risk prediction model for these patients can play a significant role in evaluating their prognosis.

Indexed as

Intensive Care UnitsNeoplasmsAgedHumansMiddle AgedPrognosisRetrospective StudiesRisk AssessmentRisk Factors

Identifiers

PMID38102299
PMCPMC10724261
OpenAlexW4389780978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.